Insights

Outsourcing Your Parenteral Manufacturing – Choosing the Optimal CDMO

icons/content-types/article article

Drug Product

Track records, product handling limitations, and cost are all factors to consider when outsourcing parenteral manufacturing. Choosing the right CDMO partner is not an easy task, but Curia has resources to make the decision easier. To learn more, Pharmaceutical Technology sat down with Dr. Ronald Aungst [Vice President, Portfolio and Sourcing for Drug Product, Curia] to discuss what CDMOs have to offer and how these partnerships can improve tech transfers and drug product development.

Download the Article

Ready to move from idea to impact?

Whether you have a question for our team or an opportunity you’re eager to pursue, one of our experts can help you get started.

Contact Us
More from Curia

icons/content-types/video webinar

Antibody-Drug Conjugate (ADC) – From Bioassay Development to Linker-Payload Constructs

In this webinar, we will discuss select examples of Curia’s experience in the ADC discovery space and how some of these challenges are overcome.

icons/content-types/article article

Accelerating Therapies With Curia From Conception to Manufacturing

Partnering with a CDMO can help streamline drug development, and certain preparations can help ensure a successful collaboration. Scott Alderucci, Curia’s Director of Process Development, explores the advantages of partnering with a CDMO to navigat...